EDAP TMS S.A. - AMERICAN DEPOSITARY SHARES EACH R

EDAP Presents Positive Results from Non-Inferiority Study Comparing Outcomes of Focal One HIFU Versus Radical Prostatectomy at EAU23

21 Mar 2023 16:30:00 By Nasdaq GlobeNewswire

EDAP to Announce Fourth Quarter and Full-Year 2022 Financial Results on Thursday, March 30th

09 Mar 2023 08:00:00 By Nasdaq GlobeNewswire

EDAP Announces Record Preliminary Fourth Quarter and Full-Year 2022 Revenue

14 Feb 2023 09:00:00 By Nasdaq GlobeNewswire

EDAP Announces Positive Results from Phase 2 Study Evaluating Therapeutic High-Intensity Focused Ultrasound (HIFU) for the Treatment of Rectal Endometriosis

31 Jan 2023 08:00:00 By Nasdaq GlobeNewswire

EDAP Announces Record Q4 US Focal One Placements

05 Jan 2023 08:00:00 By Nasdaq GlobeNewswire

EDAP Appoints Medical Capital Equipment Finance Veteran Ken Mobeck as Chief Financial Officer of Company’s U.S. Subsidiary

06 Dec 2022 08:00:00 By Nasdaq GlobeNewswire

EDAP Announces Approval to Initiate Randomized Clinical Trial Evaluating Focal One® as a Potential Treatment for Rectal Deep Infiltrating Endometriosis

30 Nov 2022 16:01:00 By Nasdaq GlobeNewswire

EDAP to Present at the Piper Sandler 34th Annual Healthcare Conference

21 Nov 2022 08:00:00 By Nasdaq GlobeNewswire

EDAP Reports Third Quarter 2022 Results

16 Nov 2022 16:35:00 By Nasdaq GlobeNewswire

EDAP TMS SA to Announce Third Quarter 2022 Financial Results on Wednesday, November 16th, 2022

02 Nov 2022 08:00:00 By Nasdaq GlobeNewswire

EDAP Announces Focal One® HIFU Reimbursement Raised to Urology APC Level 6 Under CMS Outpatient Prospective Payment System (OPPS) Final Rule for CY23

01 Nov 2022 17:22:22 By Nasdaq GlobeNewswire

EDAP TMS Hosting Urology Expert Panel and Live Focal One® Technology Demonstration

26 Sep 2022 08:00:00 By Nasdaq GlobeNewswire

EDAP Announces Pricing of Public Offering of American Depositary Shares

22 Sep 2022 20:54:06 By Nasdaq GlobeNewswire

EDAP Announces Proposed Public Offering of American Depositary Shares

22 Sep 2022 16:01:00 By Nasdaq GlobeNewswire

EDAP Reports Second Quarter 2022 Results

24 Aug 2022 16:35:00 By Nasdaq GlobeNewswire

EDAP TMS SA to Announce Second Quarter 2022 Financial Results on August 24th, 2022

03 Aug 2022 08:00:00 By Nasdaq GlobeNewswire

EDAP Announces Focal One® HIFU Reimbursement Raised to Urology APC Level 6 Under CMS Outpatient Prospective Payment System (OPPS) Proposed Rule for CY23

18 Jul 2022 07:00:00 By Nasdaq GlobeNewswire

EDAP’s Focal One® HIFU to be Showcased at Two Major Robotics & Urology International Congresses

28 Jun 2022 09:00:00 By Nasdaq GlobeNewswire

EDAP holds a Symposium at 6th European Endometriosis Congress

14 Jun 2022 08:00:00 By Nasdaq GlobeNewswire

EDAP Announces Multiple Oral Presentations at the 21st International Symposium on Therapeutic Ultrasound

06 Jun 2022 08:00:00 By Nasdaq GlobeNewswire